PMDA drug package insert
ビオスリーHi錠
PMDA OTC drug · アリナミン製薬（株） · package insert Mar 19, 2024
Key facts
| Brand names | ビオスリーHi錠 |
|---|---|
| Companies | 製造販売元／東亜薬品工業（株）,販売会社／アリナミン製薬（株） |
| Product type | OTC drug |
| OTC risk class | なし |
| OTC dosage form | 錠剤 |
| OTC effect category | 整腸薬 |
| Package insert date | Mar 19, 2024 |
| PMDA document key | 480019_J0601002428 |
| PMDA company code | 480019 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: